Stabilization of hepatitis C associated collapsing focal segmental glomerulosclerosis with interferon alpha-2a and

Insights

Hepatitis C virus (HCV) infection can cause kidney disease. A case study shows that interferon and ribavirin therapy stabilized HCV-associated collapsing focal segmental glomerulosclerosis (cFSGS) in advanced kidney disease.

Area of Science:

  • Nephrology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infection is linked to various glomerular diseases.
  • Cryoglobulin-associated membranoproliferative glomerulonephritis Type I is the most common HCV-related kidney disease.
  • Focal segmental glomerulosclerosis (FSGS) is rarely reported with HCV, but de novo collapsing FSGS (cFSGS) is noted during interferon treatment.

Observation:

  • This report details a specific case of HCV-associated cFSGS.
  • The patient presented with advanced kidney disease.

Findings:

  • The patient's HCV-associated cFSGS was stabilized.
  • Combination therapy with interferon α-2a and ribavirin was utilized.
  • This treatment approach proved effective in managing the kidney condition.

Implications:

  • Interferon and ribavirin combination therapy can be a viable treatment for HCV-associated cFSGS.
  • This case highlights a potential therapeutic strategy for patients with HCV and kidney complications.
  • Further research may explore the efficacy of antiviral therapies in managing HCV-related nephropathies.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...